Santos-López Gerardo, Panduro Arturo, Sosa-Jurado Francisca, Fierro Nora A, Lira Rosalía, Márquez-Domínguez Luis, Cerbón Marco, Méndez-Sánchez Nahum, Roman Sonia
Laboratorio de Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Metepec 74360, Mexico.
National Network of Viral Hepatitis Researchers, Mexico City, Mexico.
Pathogens. 2024 Oct 1;13(10):859. doi: 10.3390/pathogens13100859.
Viral hepatitis (A-E) presents a major global health challenge. In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis, with the aim of reducing new infections by 90% and deaths by 65% by 2030. Mexico is one of 38 focus countries identified by the WHO, collectively accounting for 80% of global infections and deaths. While hepatitis B and C are commonly diagnosed in Mexico, routine diagnosis for hepatitis D and E is lacking, with no specific epidemiological data available. In 2020, Mexico implemented the National Hepatitis C Elimination Program, focusing on preventing new infections, reducing complications like cirrhosis and hepatocellular carcinoma, ensuring access to treatment, and improving patient care. However, this program has not been extended to hepatitis B and E. Addressing the challenges of viral hepatitis control in Mexico requires increased resource allocation, expanded diagnosis, vaccination for hepatitis A and B, and treatment coverage for hepatitis B and C, along with multisectoral engagement. This work provides an overview of Mexico's response to the global initiative, highlighting its progress, challenges, and areas of opportunity.
病毒性肝炎（A - E型）是一项重大的全球卫生挑战。2015年，世界卫生组织（WHO）发起了一项消除病毒性肝炎的倡议，目标是到2030年将新感染病例减少90%，将死亡人数减少65%。墨西哥是WHO确定的38个重点国家之一，这些国家的感染和死亡病例合计占全球的80%。虽然墨西哥常见乙型和丙型肝炎的诊断，但丁型和戊型肝炎缺乏常规诊断，也没有具体的流行病学数据。2020年，墨西哥实施了国家丙型肝炎消除计划，重点是预防新感染、减少肝硬化和肝细胞癌等并发症、确保获得治疗以及改善患者护理。然而，该计划尚未扩展到乙型和戊型肝炎。应对墨西哥病毒性肝炎控制的挑战需要增加资源分配、扩大诊断、开展甲型和乙型肝炎疫苗接种、提高乙型和丙型肝炎的治疗覆盖率，以及多部门参与。这项工作概述了墨西哥对全球倡议的应对情况，突出了其进展、挑战和机遇领域。
